(Reuters) – London-listed drugmaker Shire Plc and Japan’s Takeda Pharmaceutical Co Ltd plan to announce a preliminary deal on Wednesday, after the latter sweetened its $62 billion acquisition offer, people familiar with the matter said.
Source:: Reuters – Business News
